about
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentLong-term treatment with citicoline may improve poststroke vascular cognitive impairment.Validation of the Spanish Version of the Face Name Associative Memory Exam (S-FNAME) in Cognitively Normal Older Individuals.Concordance between Subjective and Objective Memory Impairment in Volunteer Subjects.Neurological damage after transcatheter aortic valve implantation compared with surgical aortic valve replacement in intermediate risk patients.Social Representation of Dementia: An Analysis of 5,792 Consecutive Cases Evaluated in a Memory Clinic.Evaluation of Candidate Genes Related to Neuronal Apoptosis in Late-Onset Alzheimer’s Disease.Cognitive improvement in patients with severe carotid artery stenosis after transcervical stenting with protective flow reversal.Reperfusion after stroke sonothrombolysis with microbubbles may predict intracranial bleeding.FACEHBI: A Prospective Study of Risk Factors, Biomarkers and Cognition in a Cohort of Individuals with Subjective Cognitive Decline. Study Rationale and Research Protocols.Anger Assessment in Patients Treated With Brivaracetam.Impact of Recruitment Methods in Subjective Cognitive Decline.Asymptomatic carotid stenosis and cognitive improvement using transcervical stenting with protective flow reversal technique.Usefulness of peripapillary nerve fiber layer thickness assessed by optical coherence tomography as a biomarker for Alzheimer's diseaseExploring Genetic Associations of Alzheimer’s Disease Loci With Mild Cognitive Impairment Neurocognitive EndophenotypesVisual impairment in aging and cognitive decline: experience in a Memory Clinic.No evidence of APP point mutation and locus duplication in individuals with cerebral amyloid angiopathyEvaluation of macular thickness and volume tested by optical coherence tomography as biomarkers for Alzheimer's disease in a memory clinic[Social cognition and cognitive functions in patients with epilepsy treated with eslicarbazepine acetate]
P50
Q33629452-BB7E13F9-5698-4B3D-8714-041F5BA9098FQ34648243-21ADB127-1B49-4FA8-B486-E835BDAA6D1AQ36573598-D8A4E1B8-E790-4EC0-9005-E19565B99A5DQ40457852-A0B8725A-8050-4904-AE56-26C1B2571F23Q41066776-8A58FCC7-D5C8-4EAC-A745-3003562569A6Q41103306-0177D7D2-63C8-4F6D-B80A-770018848B41Q41542106-C66C4AFE-CE29-4901-A89A-128CB36BFF8FQ43417419-1F78D765-8E01-48D8-81A8-98E4100D40A3Q44652940-BA61C0D8-2F13-4343-A125-73D4706C7C29Q46252015-E46058A3-2EDA-4E04-9809-24C1D0782A8CQ47690872-597E48D5-FFF0-4C4A-9C32-2B596B5C93FCQ47952621-BD599BD5-8262-42A2-92DA-08479A0EC246Q48080105-33D443FF-A50F-4509-9D12-F50B49718E03Q58612352-252BCFB6-139D-4CC3-85F3-9D23CB4C4123Q58693792-D84727A3-F847-437B-AB55-D6F6BD673D96Q64933272-72FE5936-228A-4457-B80B-18D36BC2940BQ83778314-EF7B0B14-2DC7-4014-9629-247F2E156F11Q89474940-24FCCC39-55BA-4929-8B9F-58B059AB9326Q95540877-75B81AE7-1F36-43F3-93A3-B649C9CCE9AC
P50
description
researcher ORCID ID = 0000-0002-7479-4072
@en
wetenschapper
@nl
name
Gemma Ortega
@ast
Gemma Ortega
@en
Gemma Ortega
@es
Gemma Ortega
@nl
type
label
Gemma Ortega
@ast
Gemma Ortega
@en
Gemma Ortega
@es
Gemma Ortega
@nl
altLabel
G Ortega
@en
GEMMA ORTEGA
@en
prefLabel
Gemma Ortega
@ast
Gemma Ortega
@en
Gemma Ortega
@es
Gemma Ortega
@nl
P106
P21
P31
P496
0000-0002-7479-4072